We are live on
!
Find out more
Regeneron Pharmaceuticals
REGN
REGN
561 hedge funds and large institutions have $36.1B invested in Regeneron Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 230 increasing their positions, 177 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
46% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 50
30% more repeat investments, than reductions
Existing positions increased: 230 | Existing positions reduced: 177
14% more funds holding in top 10
Funds holding in top 10: 22 → 25 (+3)
4% more funds holding
Funds holding: 540 → 561 (+21)
4% less capital invested
Capital invested by funds: $37.7B → $36.1B (-$1.6B)
25% less call options, than puts
Call options by funds: $678M | Put options by funds: $905M
Holders
561
Holders Change
+21
Holders Change %
+3.89%
% of All Funds
15.67%
Holding in Top 10
25
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+13.64%
% of All Funds
0.7%
New
73
Increased
230
Reduced
177
Closed
50
Calls
$678M
Puts
$905M
Net Calls
-$227M
Net Calls Change
+$24.3M
Top Buyers
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$530M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$258M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$178M |
| 4 |
Morgan Stanley
New York
|
-$176M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$173M |
